A review of the medical treatment of primary sclerosing cholangitis in the 21st century

ACG Clinical Guideline: Primary Sclerosing Cholangitis

(2015) Keith D Lindor et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Meta-analysis of the effectiveness and safety of vedolizumab for ulcerative colitis

(2015) Yu Jin   WORLD JOURNAL OF GASTROENTEROLOGY

Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study

(2013) J. H. Tabibian et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Association Between Reduced Levels of Alkaline Phosphatase and Survival Times of Patients With Primary Sclerosing Cholangitis

(2013) Lina Lindström et al.   Clinical Gastroenterology and Hepatology

Effect of Ursodeoxycholic Acid Use on the Risk of Colorectal Neoplasia in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease

(2013) Siddharth Singh et al.   INFLAMMATORY BOWEL DISEASES

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

(2013) Jimmy Z Liu et al.   NATURE GENETICS

A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn’s Disease

(2013) Satish Keshav et al.   PLoS One

Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis

(2013) James H. Tabibian et al.   Biomed Research International

Review article: overlap syndromes and autoimmune liver disease

(2012) P. J. Trivedi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia

(2012) L. Lindström et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease

(2012) Kirsten Boonstra et al.   INFLAMMATORY BOWEL DISEASES

Improvement of serum alkaline phosphatase to

(2012) Said Al Mamari et al.   JOURNAL OF HEPATOLOGY

Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis

(2011) C. K. Triantos et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis

(2011) M. H. Imam et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

High-Dose Ursodeoxycholic Acid Is Associated With the Development of Colorectal Neoplasia in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis

(2011) John E Eaton et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Guidelines for the management of inflammatory bowel disease in adults

(2011) C. Mowat et al.   GUT

Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis

(2011) Tobias Mueller et al.   LIVER INTERNATIONAL

Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas

(2010) Ymera Pignochino et al.   BMC CANCER

Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis

(2010) Ahmed A. Negm et al.   GASTROINTESTINAL ENDOSCOPY

Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells

(2010) Hongwei He et al.   HEPATOLOGY

Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression

(2010) Emmanouil Sinakos et al.   HEPATOLOGY

Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea

(2010) Byong Duk Ye et al.   INFLAMMATORY BOWEL DISEASES

Bezafibrate for the treatment of primary sclerosing cholangitis

(2010) Suguru Mizuno et al.   JOURNAL OF GASTROENTEROLOGY

Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis

(2010) Hitoshi Sano et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis

(2010) Eleonora Patsenker et al.   JOURNAL OF HEPATOLOGY

Retinoic acid represses CYP7A1 expression in human hepatocytes and HepG2 cells by FXR/RXR-dependent and independent mechanisms

(2010) Shi-Ying Cai et al.   JOURNAL OF LIPID RESEARCH

β-Adrenoceptor blockade in sclerosing cholangitis of Mdr2 knockout mice: antifibrotic effects in a model of nonsinusoidal fibrosis

(2010) Ingo Strack et al.   LABORATORY INVESTIGATION

Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment

(2010) Vivian Barry-Hamilton et al.   NATURE MEDICINE

Gut Homing Receptors on CD8 T Cells Are Retinoic Acid Dependent and Not Maintained by Liver Dendritic or Stellate Cells

(2009) Bertus Eksteen et al.   GASTROENTEROLOGY

Genome-Wide Association Analysis in Primary Sclerosing Cholangitis

(2009) Tom H. Karlsen et al.   GASTROENTEROLOGY

Diagnosis and management of primary sclerosing cholangitis

(2009) Roger Chapman et al.   HEPATOLOGY

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

(2009) Keith D. Lindor et al.   HEPATOLOGY

Autoimmune pancreatitis/IgG4-associated cholangitis and primary sclerosing cholangitis – Overlapping or separate diseases?

(2009) George J.M. Webster et al.   JOURNAL OF HEPATOLOGY

Long-term Treatment of Primary Sclerosing Cholangitis in Children With Oral Vancomycin: An Immunomodulating Antibiotic

(2009) Yinka K Davies et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Retinoids as Critical Modulators of Immune Functions: New Therapeutic Perspectives for Old Compounds

(2009) Michele Montrone et al.   Endocrine Metabolic & Immune Disorders-Drug Targets

Minocycline in the Treatment of Patients With Primary Sclerosing Cholangitis: Results of a Pilot Study

(2008) Marina G Silveira et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

A Double-blind, Placebo-controlled, Randomized Study of Infliximab in Primary Sclerosing Cholangitis

(2008) Daan W. Hommes et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective

(2008) Susan N. Cullen et al.   JOURNAL OF HEPATOLOGY

Ursodeoxycholic Acid Suppresses Cox-2 Expression in Colon Cancer: Roles of Ras, p38, and CCAAT/Enhancer-Binding Protein

(2008) Sharad Khare et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL